The PennZone

  • Home
  • Entertainment
  • Marketing
  • Music
  • Books
  • Non-profit
  • Education
  • Sports
  • Legal

Electroshock and Antidepressants: Hidden Dangers in Misdiagnosed Holiday Blues
The PennZone/10291181

Trending...
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
  • LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
  • Where Do Missouri Plane Crashes Really Happen? Not Where You'd Think
ECT and Antidepressants: Hidden Dangers
A new study reveals widespread misinformation about electroshock therapy among patients. CCHR says parents are similarly misled about ECT use on teens and children as young as five. Moreover, antidepressants—often a precursor to ECT recommendations—also carry significant risks.

LOS ANGELES - PennZone -- A new study reveals that patients feel misinformed about the risks of electroconvulsive therapy (ECT), reinforcing the argument that the practice should be banned, according to mental health industry watchdog, Citizens Commission on Human Rights International. Study participants shared accounts of immediate cognitive and memory impairments, as well as long-term effects such as profound loss of abilities, memory, humanity, and personal connections, along with psychological harm and a sense of brain damage. Published in Qualitative Health Research, the study highlights that many patients are denied recognition of their adverse outcomes, which intensifies their struggles.[1]

CCHR says that in the U.S., young teens and children under six have undergone ECT. Lacking the ability to consent, parents—often misinformed about its safety and efficacy—agree to the practice. They are likely unaware that no clinical trials have substantiated safety and efficacy.

The information leaflets provided to patients regarding ECT have been found to minimize the prevalence or severity of memory loss, researchers found. The study says, "Following ECT, there is a possibility of permanent adverse effects including memory and cognitive impairment" and that "Iatrogenic harm, the infliction of harm through medical interventions, is a known possible outcome of ECT."

While the survey of consumers occurred in the United Kingdom, CCHR says that similar patient complaints about ECT have been reported to the group in the U.S. and other countries. Recently, CCHR International supported groups helping a Minnesota man who was threatened with court-ordered ECT when he refused to consent to it. The man had already received 17 courses of involuntary shock and was terrified of undergoing more.

More on The PennZone
  • Supreme Garage Door Repair Redirects Marketing Dollars Into North Texas Communities
  • RAS AP Consulting Spotlights Managed AP Governance™ at Esker All Access
  • ANSI BSR Upholds Appeal of AFDE Member Andrew Sulner, MSFS, JD, finding the AAFS Academy Standards Board (ASB) Violated ANSI Essential Requirements
  • Prolific Press Publishes 100 Word Fiction Issue #1, the Journal's Debut Anthology
  • 100 Word Fiction Releases Issue #2: Forty Stories, One Hundred Words Each

In its letter to the psychiatric hospital attempting to force ECT upon the 44-year-old man, CCHR cited numerous United Nations reports that say involuntary, forced electroshock constitutes torture and that U.S. courts have acknowledged ECT's risks to patients, including brain damage, memory loss, and cognitive disability.[2]

ECT is often recommended when other treatments have not worked, especially antidepressants. These drugs also have iatrogenic side effects. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing safety alerts for 30 antidepressants, after Thomas Kingston, husband of Lady Gabriella Kingston, daughter of Prince and Princess Michael of Kent, fatally shot himself due to adverse effects from these drugs.[3] A coroner ruled Mr. Kingston shot himself due to the adverse effect of the medications he had been prescribed, which included the common antidepressant citalopram. According to evidence given at his inquest, Mr. Kingston had complained that another antidepressant was making him anxious. A medical expert at the inquest, Dr David Healy, suggested this was a sign that SSRI antidepressants "did not suit him" and that he should not have been prescribed citalopram following this. "We need a much more explicit statement saying that these drugs can cause people to commit suicide who wouldn't have otherwise," he said.[4]

MHRA data shows 71 alerts since 2014 over deaths linked to citalopram and 114 for sertraline.[5]

According to JAMA Psychiatry, ECT is recommended after two antidepressants have failed as "first-line" treatments. CCHR says consumers are often misinformed and, therefore, are unaware that treatment side effects can drive them to have suicidal feelings. When these increase, they are further misled into believing it is their mental state "at fault," rather than the adverse mental and physical effects synonymous with both antidepressants and electroshock.

More on The PennZone
  • Kentucky's Plane Crash Data Lands Far from the State's Busiest Airports
  • StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
  • Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
  • Imagen Golf Named Exclusive Golf Instruction Partner at Wood Lane Golf and Social
  • Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality

During the holiday season, CCHR is committed to raising awareness about individuals experiencing sorrow because of a lost one, loneliness, being away from family, and more. People can become unwitting candidates for having such emotions misdiagnosed as "holiday depression," and put at risk of being prescribed antidepressants. CCHR wants to see different, non-invasive approaches taken to help individuals and strongly urges against agreeing to electroshock therapy, recommending legal support if necessary to prevent it from being forced on any individual.

Founded 55 years ago by the Church of Scientology and psychiatrist Dr. Thomas Szasz, CCHR has achieved significant milestones in mental health reform. In 1976, it played a pivotal role in securing the first-ever prohibition on electroshocking minors in California. Similarly, in 2014, CCHR helped enact legislation in Western Australia that made administering ECT to minors a criminal offense. The organization was also instrumental in prompting the Food and Drug Administration to hold hearings on the potential suicidal effects of SSRI antidepressants, leading to the FDA issuing warnings of suicidal ideation for individuals under 24.
Sources:

[1] Emily Shipwright, David Murphy, "Long-Term Adverse Effects After Electroconvulsive Therapy (ECT): A Narrative Analysis Exploring People's Experiences, Meaning-Making, and Coping," Qualitative Health Research, 2024, journals.sagepub.com/doi/10.1177/10497323241303391

[2] "CCHR Supports Minnesota Man's Opposition to Enforced Electroshock Treatment," CCHR International, 4 Dec. 2024, www.cchrint.org/2024/12/04/cchr-supports-opposition-to-enforced-electroshock-treatment/

[3] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[4] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

[5] "More than 100 alerts over deaths linked to antidepressants taken by Thomas Kingston," The Independent, 8 Dec. 2024, www.independent.co.uk/news/health/antidepressant-citalopram-thomas-kingston-b2658665.html

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Obsolete Industrial Expands Its Membership
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
  • Four-Time Olympian Joetta Clark Diggs to Compete at World Masters Athletics Championships in Daegu
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
  • The Alistair Apartments Reaches 95% Occupancy in Downtown Lancaster, PA
  • Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
  • Where Do Missouri Plane Crashes Really Happen? Not Where You'd Think
  • LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
  • Kellyn Endorses National Push to Expand Food is Medicine
  • LATO AI Automates Customer Communication to Help CSide Sports Academy and BAT 24 Nation Grow
  • Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
  • Tina Hasselbusch, Turnstone Creative Co-founder and Chief Executive Officer, Named to LVB 300
  • Pittsburgh Family Law Attorneys at Pollock Begg Earn Top Honors in 2027 Best Lawyers Guide
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • Free Commercial Glass Estimating and Code Compliance Tools Launched by Landmark Construction - The Leading Glass Company in Los Angeles
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Slotozilla Reports Strong Growth in Q2 2026

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 858
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments - 117
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
  • Nola Blue Records Announces New Album from Sherman Holmes
  • Salestrics Introduces PraiseEngine: The AI-Native Review Engine Built to Fix Social Proof
  • Meals on Wheels of the Greater Lehigh Valley Receives $15,000 PPL Foundation Grant to Expand Access

Similar on PennZone

  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • NaturismRE expands international research programme with Health & Wellbeing Survey
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us